Your browser does not support JavaScript or it may be disabled!
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
Get Realtime News
on your webpage

About 828 results for "sanofi country"

Sanofi-Synthelabo India launches 2 diabetes drugs
Financial Express

Sanofi-Synthelabo India launches 2 diabetes drugs

Drug firm Sanofi-Synthelabo India has expanded Sanofi's diabetes portfolio in the country with launch of two drugs - Lyxumia and Zemiglo - for lowering blood sugar levels. While Lyxumia is a once daily, non-insulin injectable drug, Zemiglo is a ... Business Standard, 6 days ago

16 images for sanofi country

Financial Express, 6 days ago, 1 week ago
Pharma Letter, 2 weeks ago
Pharma Letter, 1 month ago
Pharma Letter, 1 month ago
MDLinx, 3 months ago
EuroInvestor, 3 months ago
EuroInvestor, 3 months ago, 3 months ago
Qatar is Booming, 4 months ago

Sanofi recalls some Combiflam batches

Some batches of popular painkiller Combiflam is being withdrawn in India after the country’s drugs regulator found them substandard, said French drugmaker Sanofi. Some batches of Combi-flam were found to be “not of standard quality” as they failed ...
 Asian Age2 months ago Drug watchdog again finds Combiflam substandard  Smart Investor2 weeks ago Sanofi recalls some batches of Combiflam in India  The Hindu2 months ago Tough pill to swallow: Batches of Combiflam withdrawn for being sub-standard  catchnews.com2 months ago

Our ex-employees want to rejoin us

With nearly one lakh employees in more than 100 countries, Sanofi is the world’s fourth largest pharmaceutical company and the biggest in Europe and emerging markets. Its vaccine division, Sanofi Pasteur, is arguably the world leader in human vaccine ...
 The Financial Chronicle2 months ago

The PCSK9 countdown: Amgen's Repatha wins EU race, with Sanofi's Praluent up Friday at FDA

Amgen's ($AMGN) new cholesterol fighter may be second in line for FDA approval in the U.S. But in Europe, it's officially first. Amgen's PCSK9 contender Repatha slipped past Sanofi ($SNY) and Regeneron's ($REGN) Praluent to win E.U. approval ...
 FiercePharma2 weeks ago

Gibbs Law Group Files Federal Taxotere Hair Loss Lawsuit on Behalf of Breast Cancer Survivor

OAKLAND, Calif.--( BUSINESS WIRE )--Gibbs Law Group has filed a federal lawsuit against Sanofi-Aventis alleging that the company failed to warn breast cancer patients that they may experience permanent, disfiguring hair loss, or alopecia, following ...
 Business Wire11 hours ago GIBBS LAW GROUP : Files Federal Taxotere Hair Loss Lawsuit on Behalf of Breast Cancer Survivor  4 Traders11 hours ago

Sanofi-Synthelabo unveils 2 new diabetic drugs

Sanofi-Synthelabo (India) Pvt Ltd has launched two drugs for type-2 diabetes patients in India Lyxumia (lixisenatide) and Zemiglo (gemigliptin). Lyxumia, a non-insulin injectable drug, is approved in over 70 countries and commercially launched in ...
 The Hindu6 days ago Sanofi launches diabetes drugs, Lyxumia and Zemiglo in India  PharmaBiz6 days ago Sanofi India expands diabetes portfolio  Express Pharma6 days ago

Warming climate puts more Pinoys at greater risk for dengue

By: , July 23rd, 2016 12:14 AM Infographics provided by sanofi-aventis Philippines The World Health Organization regards dengue as the world's most dominant mosquito-borne viral disease with incident rates that have increased 30-fold in the past ...
 Philippine Daily Inquirer3 days ago

Advanced Enzyme Tech IPO Opens: Here's What Management Said

Advanced Enzyme Technologies exports to 50 different countries and has 0.9% market shares globally. Advanced Enzyme Technologies, which launched its initial public offer (IPO) to raise around Rs 410 crore today, will utilise part of the proceeds ...
 NDTV5 days ago Subscribe to Advanced EnzymeTechnologies IPO: Geojit BNP Paribas  Moneycontrol.com5 days ago Advanced Enzyme Technologies coming with an IPO to raise around Rs 412 Cr  Finalaya.com1 week ago

[Comment] SAGE committee advice on dengue vaccine

Dengue remains a major global public health problem with 390 million cases in more than 100 countries reported annually, mostly in developing countries. In the absence of treatment modalities, and with often suboptimal vector control, preventive ...
 Lancet Neurology6 days ago

AstraZeneca plc (ADR) Plans to Step into the Medivation Inc Battle: a Threat for Sanofi?

AstraZeneca Plc ADR ( NYSE:AZN ) is considering to put forward a formal offer of $10 billion ((£7.7 billion) for Medivation. The British pharma giant is said to have retained an interest in the cancer drug maker since April, when rumors initially ...
 Bidness Etc1 week ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts


Realtime News

on your Webpage

Add Widget >Get your members hooked!
Get updated on latest news & your favorite topics right in your inbox!
More     Less